CoChat
Sign Up
Cited by 168

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts

Oketch-Rabah, Hellen A., Roe, Amy L., Rider, Cynthia V., Bonkovsky, Herbert L., Giancaspro, Gabriel I., Navarro, Victor, Paine, Mary F., Betz, Joseph M., Marles, Robin J., Casper, Steven, Gurley, Bill, Jordan, Scott A., He, Kan, Kapoor, Mahendra P., Rao, Theertham P., Sherker, Averell H., Fontana, Robert J., Rossi, Simona, Vuppalanchi, Raj, Seeff, Leonard B., Stolz, Andrew, Ahmad, Jawad, Koh, Christopher, Serrano, Jose, Low Dog, Tieraona, Ko, Richard·2020·Toxicology Reports
DOI 10.1016/j.toxrep.2020.02.008PMC PMC7044683
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.toxrep.2020.02.008

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The United States Pharmacopeia and DILIN members confirmed that GTE are potentially hepatotoxic by using the updated RUCAM.

    “Key issues around liver injury by GTE are obviously settled now, as the United States Pharmacopeia and DILIN members finally made it and confirmed that GTE are potentially hepatotoxic by using the updated RUCAM and thereby breaking boundaries to good medicine based on evidence and a diagnostic algorithm in line with artificial intelligence proposals.99”

    From Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases (2020) · cites this paper as [99]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 168

  1. Chaturvedula, 2011, The aroma, taste, color and bioactive constituents of tea, J. Med. Plants Res., 5, 2110
  2. Jurgens, 2012, Green tea for weight loss and weight maintenance in overweight or obese adults, Cochrane Database Syst. Rev.
  3. Bonkovsky, 2006, Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis), Ann. Intern. Med., 144, 68, 10.7326/0003-4819-144-1-200601030-00020 · DOI
  4. Araujo, 2015, Acute liver injury associated with a newer formulation of the herbal weight loss supplement Hydroxycut, BMJ Case Rep., 10.1136/bcr-2015-210303 · DOI
  5. Brown, 2008, Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial, Br. J. Nutr., 101, 886, 10.1017/S0007114508047727 · DOI
  6. Dekant, 2017, Safety assessment of green tea based beverages and dried green tea extracts as nutritional supplements, Toxicol. Lett., 277, 104, 10.1016/j.toxlet.2017.06.008 · DOI
  7. EFSA, 2018, EFSA J., 16, e05239
  8. Hu, 2018, The safety of green tea and green tea extract consumption in adults–results of a systematic review, Regul. Toxicol. Pharmacol., 95, 412, 10.1016/j.yrtph.2018.03.019 · DOI
  9. Mazzanti, 2009, Hepatotoxicity from green tea: a review of the literature and two unpublished cases, Eur. J. Clin. Pharmacol., 65, 331, 10.1007/s00228-008-0610-7 · DOI
  10. Navarro, 2013, Catechins in dietary supplements and hepatotoxicity, Dig. Dis. Sci., 58, 2682, 10.1007/s10620-013-2687-9 · DOI
  11. Patel, 2013, Green tea extract: a potential cause of acute liver failure, World J. Gastroenterol., 19, 5174, 10.3748/wjg.v19.i31.5174 · DOI
  12. Yates, 2017, Bioactive nutrients-time for tolerable upper intake levels to address safety, Regul. Toxicol. Pharmacol., 84, 94, 10.1016/j.yrtph.2017.01.002 · DOI
  13. Yu, 2017, Effect of green tea supplements on liver enzyme elevation: results from a randomized intervention study in the United States, Cancer Prev. Res. Phila. (Phila), 10, 571, 10.1158/1940-6207.CAPR-17-0160 · DOI
  14. Sarma, 2008, Safety of green tea extracts: a systematic review by the US Pharmacopeia, Drug Saf., 31, 469, 10.2165/00002018-200831060-00003 · DOI
  15. Teschke, 2012, Suspected herbal hepatotoxicity: requirements for appropriate causality assessment by the US Pharmacopeia, Drug Saf., 35, 1091, 10.1007/BF03261996 · DOI
  16. Bedrood, 2018, Toxicological effects of Camellia sinensis (green tea): a review, Phytother. Res., 32, 1163, 10.1002/ptr.6063 · DOI
  17. Fontana, 2009, Drug-induced liver injury network (DILIN) prospective study, Drug Saf., 32, 55, 10.2165/00002018-200932010-00005 · DOI · Paper page
  18. Teschke, 2019, Suspected herb induced liver injury by green tea extracts: critical review and case 2 analysis applying RUCAM for causality assessment, Jpn. J. Gastroenterol. Hepatol., 1, 1
  19. Danan, 1993, Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries, J. Clin. Epidemiol., 46, 1323, 10.1016/0895-4356(93)90101-6 · DOI · Paper page
  20. Danan, 2015, RUCAM in drug and herb induced liver injury: the update, Int. J. Mol. Sci., 17, 10.3390/ijms17010014 · DOI · Paper page
  21. Rochon, 2008, Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury, Hepatology, 48, 1175, 10.1002/hep.22442 · DOI
  22. Agarwal, 2010, Important elements for the diagnosis of drug-induced liver injury, Clin. Gastroenterol. Hepatol., 8, 463, 10.1016/j.cgh.2010.02.008 · DOI
  23. Vuong, 2012, Improved extraction of green tea components from teabags using the microwave oven, J. Food Compos. Anal., 27, 95, 10.1016/j.jfca.2012.06.001 · DOI
  24. Friedman, 2005, Distribution of catechins, theaflavins, caffeine, and theobromine in 77 teas consumed in the United States, J. Food Sci., 70, 10.1111/j.1365-2621.2005.tb08304.x · DOI
  25. Friedman, 2006, HPLC analysis of catechins, theaflavins, and alkaloids in commercial teas and green tea dietary supplements: comparison of water and 80% ethanol/water extracts, J. Food Sci., 71, 10.1111/j.1750-3841.2006.00090.x · DOI
  26. Banerjee, 2015, Efficient extraction strategies of tea (Camellia sinensis) biomolecules, J. Food Sci. Technol., 52, 3158
  27. Lorenzo, 2016, Phenolic compounds of green tea: health benefits and technological application in food, Asian Pac. J. Trop. Biomed., 6, 709, 10.1016/j.apjtb.2016.06.010 · DOI
  28. Perva-Uzunalić, 2006, Extraction of active ingredients from green tea (Camellia sinensis): extraction efficiency of major catechins and caffeine, Food Chem., 96, 597, 10.1016/j.foodchem.2005.03.015 · DOI
  29. Ziaedini, 2010, Extraction of antioxidants and caffeine from green tea (Camelia sinensis) leaves: kinetics and modeling, Rev. Agaroquimica Y Tecnol. Aliment., 16, 505
  30. Seddik, 2001, Y at-il des risques d’hépatotoxicité avec Exolise®, Gastroenterol. Clin. Biol., 25, 834
  31. Paramasivam, 2014, Persistence behaviour of deltamethrin on tea and its transfer from processed tea to infusion, Chemosphere, 111, 291, 10.1016/j.chemosphere.2014.03.111 · DOI
  32. Wang, 2014, Determination of pesticide residue transfer rates (percent) from dried tea leaves to brewed tea, J. Agric. Food Chem., 62, 966, 10.1021/jf404123h · DOI
  33. Xue, 2014, Transfer of difenoconazole and azoxystrobin residues from chrysanthemum flower tea to its infusion, Food Addit. Contam. Part A, 31, 666, 10.1080/19440049.2014.882020 · DOI
  34. Hayward, 2015, Determinations for pesticides on Black, Green, Oolong, and White Teas by gas chromatography triple-quadrupole mass spectrometry, J. Agric. Food Chem., 63, 8116, 10.1021/acs.jafc.5b02860 · DOI
  35. Muraleedharan, 2004, Strategies for reducing pesticide residues in tea, Int. J. Tea Sci., 3
  36. Fernández-Cáceres, 2001, Differentiation of tea (Camellia sinensis) varieties and their geographical origin according to their metal content, J. Agric. Food Chem., 49, 4775, 10.1021/jf0106143 · DOI
  37. Ratnaike, 2003, Acute and chronic arsenic toxicity, Postgrad. Med. J., 79, 391, 10.1136/pmj.79.933.391 · DOI · Paper page
  38. Järup, 1998, Health effects of cadmium exposure–a review of the literature and a risk estimate, Scand. J. Work Environ. Health, 1
  39. Vincent, 2003, The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle development agent, Sports Med., 33, 213, 10.2165/00007256-200333030-00004 · DOI
  40. Cerulli, 1998, Chromium picolinate toxicity, Ann. Pharmacother., 32, 428, 10.1345/aph.17327 · DOI
  41. Farmand, 2005, Lead-induced dysregulation of superoxide dismutases, catalase, glutathione peroxidase, and guanylate cyclase, Environ. Res., 98, 33, 10.1016/j.envres.2004.05.016 · DOI
  42. Lee, 2017, Blood mercury concentrations are associated with decline in liver function in an elderly population: a panel study, Environ. Health, 16, 17, 10.1186/s12940-017-0228-2 · DOI
  43. Spangler, 2012, Air manganese levels and chronic liver disease mortality in North Carolina counties: an ecological study, Int. J. Environ. Res. Public Health, 9, 3258, 10.3390/ijerph9093258 · DOI
  44. Garcia-Nino, 2014, Protective effect of curcumin against heavy metals-induced liver damage, Food Chem. Toxicol., 69, 182, 10.1016/j.fct.2014.04.016 · DOI
  45. Jaishankar, 2014, Toxicity, mechanism and health effects of some heavy metals, Interdiscip. Toxicol., 7, 60, 10.2478/intox-2014-0009 · DOI · Paper page
  46. EFSA, 2016, Dietary exposure assessment to pyrrolizidine alkaloids in the European population, Efsa J., 14, e04572
  47. Bodi, 2014, Determination of pyrrolizidine alkaloids in tea, herbal drugs and honey, Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess., 31, 1886, 10.1080/19440049.2014.964337 · DOI
  48. EFSA, 2012, Compendium of botanicals reported to contain naturally occuring substances of possible concern for human health when used in food and food supplements, EFSA J., 10, 2663
  49. EFSA, 2017, Risks for human health related to the presence of pyrrolizidine alkaloids in honey, tea, herbal infusions and food supplements, EFSA J., 15, e04908
  50. Madge, 2015, Pyrrolizidine alkaloids in herbal teas for infants, pregnant or lactating women, Food Chem., 187, 491, 10.1016/j.foodchem.2015.04.067 · DOI
  51. Merz, 2016, Interim relative potency factors for the toxicological risk assessment of pyrrolizidine alkaloids in food and herbal medicines, Toxicol. Lett., 263, 44, 10.1016/j.toxlet.2016.05.002 · DOI
  52. Mulder, 2018, Occurrence of pyrrolizidine alkaloids in animal- and plant-derived food: results of a survey across Europe, Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess., 35, 118, 10.1080/19440049.2017.1382726 · DOI
  53. Shimshoni, 2015, Pyrrolizidine and tropane alkaloids in teas and the herbal teas peppermint, rooibos and chamomile in the Israeli market, Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess., 32, 2058
  54. Navarro, 2017, Liver injury from herbal and dietary supplements, Hepatology, 65, 363, 10.1002/hep.28813 · DOI
  55. Neuman, 2015, Hepatotoxicity of pyrrolizidine alkaloids, J. Pharm. Pharm. Sci., 18, 825, 10.18433/J3BG7J · DOI
  56. Chow, 2001, Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E, Cancer Epidemiol. Biomarkers Prev., 10, 53
  57. Chow, 2003, Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals, Clin. Cancer Res., 9, 3312
  58. Ullmann, 2004, Plasma-kinetic characteristics of purified and isolated green tea catechin epigallocatechin gallate (EGCG) after 10 days repeated dosing in healthy volunteers, Int. J. Vitam. Nutr. Res., 74, 269, 10.1024/0300-9831.74.4.269 · DOI
  59. Ullmann, 2003, A single ascending dose study of epigallocatechin gallate in healthy volunteers, J. Int. Med. Res., 31, 88, 10.1177/147323000303100205 · DOI
  60. Egert, 2013, Simultaneous ingestion of dietary proteins reduces the bioavailability of galloylated catechins from green tea in humans, Eur. J. Nutr., 52, 281, 10.1007/s00394-012-0330-8 · DOI
  61. Rashidinejad, 2017, Addition of milk to tea infusions: helpful or harmful? Evidence from in vitro and in vivo studies on antioxidant properties, Crit. Rev. Food Sci. Nutr., 57, 3188, 10.1080/10408398.2015.1099515 · DOI
  62. Navarro, 2019, Liver injury from herbal and dietary supplements: an introduction, Clin. Liver Dis. (Hoboken), 14, 43, 10.1002/cld.870 · DOI
  63. Isomura, 2016, Liver-related safety assessment of green tea extracts in humans: a systematic review of randomized controlled trials, Eur. J. Clin. Nutr., 70, 1340, 10.1038/ejcn.2016.165 · DOI
  64. Shanafelt, 2013, Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia, Cancer, 119, 363, 10.1002/cncr.27719 · DOI
  65. Shanafelt, 2009, Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia, J. Clin. Oncol., 27, 3808, 10.1200/JCO.2008.21.1284 · DOI
  66. Renouf, 2013, Dose-response plasma appearance of green tea catechins in adults, Mol. Nutr. Food Res., 57, 833, 10.1002/mnfr.201200512 · DOI
  67. Bae, 2009, Albumin stabilizes (–)‐epigallocatechin gallate in human serum: binding capacity and antioxidant property, Mol. Nutr. Food Res., 53, 709, 10.1002/mnfr.200800274 · DOI
  68. Ishii, 2011, Human serum albumin as an antioxidant in the oxidation of (−)-epigallocatechin gallate: participation of reversible covalent binding for interaction and stabilization, Biosci. Biotechnol. Biochem., 75, 100, 10.1271/bbb.100600 · DOI
  69. Lee, 2002, Pharmacokinetics of tea catechins after ingestion of green tea and (−)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability, Cancer Epidemiology and Prevention Biomarkers, 11, 1025
  70. Yang, 1998, Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers, Cancer Epidemiology and Prevention Biomarkers, 7, 351
  71. Clifford, 2013, Human studies on the absorption, distribution, metabolism, and excretion of tea polyphenols, Am. J. Clin. Nutr., 98, 1619S, 10.3945/ajcn.113.058958 · DOI
  72. Auger, 2008, Bioavailability of polyphenon E flavan-3-ols in humans with an ileostomy, J. Nutr., 138, 1535S, 10.1093/jn/138.8.1535S · DOI
  73. Proniuk, 2002, Preformulation study of epigallocatechin gallate, a promising antioxidant for topical skin cancer prevention, J. Pharm. Sci., 91, 111, 10.1002/jps.10009 · DOI
  74. Roach, 2006, We-P14: 429 despite its instability, epigallocatechin gallate effective lowers serum cholesterol in the hypercholesterolaemic rabbit, Atheroscler. Suppl., 7, 441, 10.1016/S1567-5688(06)81782-4 · DOI
  75. Wang, 2008, Reaction kinetics of degradation and epimerization of epigallocatechin gallate (EGCG) in aqueous system over a wide temperature range, J. Agric. Food Chem., 56, 2694, 10.1021/jf0730338 · DOI
  76. Kucera, 2015, In vitro toxicity of epigallocatechin gallate in rat liver mitochondria and hepatocytes, Oxid. Med. Cell. Longev., 476180
  77. Oritani, 2013, Comparison of (-)-epigallocatechin-3-O-gallate (EGCG) and O-methyl EGCG bioavailability in rats, Biol. Pharm. Bull., 36, 1577, 10.1248/bpb.b13-00349 · DOI
  78. Sano, 1999, Novel antiallergic catechin derivatives isolated from oolong tea, J. Agric. Food Chem., 47, 1906, 10.1021/jf981114l · DOI
  79. Phan, 2015, Binding of dietary polyphenols to cellulose: structural and nutritional aspects, Food Chem., 171, 388, 10.1016/j.foodchem.2014.08.118 · DOI
  80. Glube, 2013, Capsule shell material impacts the in vitro disintegration and dissolution behaviour of a green tea extract, Results Pharma Sci., 3, 1, 10.1016/j.rinphs.2013.08.002 · DOI
  81. Son, 2016, Combinational enhancing effects of formulation and encapsulation on digestive stability and intestinal transport of green tea catechins, J. Microencapsul., 33, 183, 10.3109/02652048.2016.1144816 · DOI
  82. Janssens, 2015, Long-term green tea extract supplementation does not affect fat absorption, resting energy expenditure, and body composition in adults, J. Nutr., 145, 864, 10.3945/jn.114.207829 · DOI
  83. Chen, 1997, Absorption, distribution, elimination of tea polyphenols in rats, Drug Metab. Dispos., 25, 1045
  84. Zhu, 2001, Rapid conversion of tea catechins to monomethylated products by rat liver cytosolic catechol-O-methyltransferase, Xenobiotica, 31, 879, 10.1080/00498250110079798 · DOI
  85. Zhu, 2000, Oral absorption and bioavailability of tea catechins, Planta Med., 66, 444, 10.1055/s-2000-8599 · DOI
  86. Lambert, 2003, Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice, J. Nutr., 133, 4172, 10.1093/jn/133.12.4172 · DOI
  87. Suganuma, 1998, Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue, Carcinogenesis, 19, 1771, 10.1093/carcin/19.10.1771 · DOI
  88. Isbrucker, 2006, Safety studies on epigallocatechin gallate (EGCG) preparations. Part 1: genotoxicity, Food Chem. Toxicol., 44, 626, 10.1016/j.fct.2005.07.005 · DOI
  89. Hsu, 2011, A subacute toxicity evaluation of green tea (Camellia sinensis) extract in mice, Food Chem. Toxicol., 49, 2624, 10.1016/j.fct.2011.07.007 · DOI
  90. Nair, 2016, A simple practice guide for dose conversion between animals and human, J. Basic Clin. Pharm., 7, 27, 10.4103/0976-0105.177703 · DOI · Paper page
  91. National Toxicology Program (NTP), 2016, Toxicology studies of green tea extract in F344/NTac rats and B6C3F1/N mice and Toxicology and carcinogenesis studies of green tea extract in Wistar Han [Crl: wi (Han)] rats and B6C3F1/N mice, Toxicol. Program Tech. Rep. Ser., 585
  92. Chengelis, 2008, 28-Day oral (gavage) toxicity studies of green tea catechins prepared for beverages in rats, Food Chem. Toxicol., 46, 978, 10.1016/j.fct.2007.10.027 · DOI
  93. Wang, 2012, Evaluation of oral subchronic toxicity of Pu-erh green tea (camellia sinensis var. assamica) extract in Sprague Dawley rats, J. Ethnopharmacol., 142, 836, 10.1016/j.jep.2012.06.011 · DOI · Paper page
  94. Takami, 2008, Evaluation of toxicity of green tea catechins with 90-day dietary administration to F344 rats, Food Chem. Toxicol., 46, 2224, 10.1016/j.fct.2008.02.023 · DOI
  95. Morita, 2009, Safety assessment of heat-sterilized green tea catechin preparation: a 6-month repeat-dose study in rats, Food Chem. Toxicol., 47, 1760, 10.1016/j.fct.2009.04.033 · DOI
  96. Kapetanovic, 2009, Exposure and toxicity of green tea polyphenols in fasted and non-fasted dogs, Toxicology, 260, 28, 10.1016/j.tox.2009.03.007 · DOI
  97. James, 2015, Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate, Food Chem. Toxicol., 76, 103, 10.1016/j.fct.2014.12.009 · DOI
  98. Wu, 2011, Green tea extract-induced lethal toxicity in fasted but not in nonfasted dogs, Int. J. Toxicol., 30, 19, 10.1177/1091581810387445 · DOI · Paper page
  99. Samavat, 2015, The Minnesota Green Tea Trial (MGTT), a randomized controlled trial of the efficacy of green tea extract on biomarkers of breast cancer risk: study rationale, design, methods, and participant characteristics, Cancer Causes Control, 26, 1405
  100. Dostal, 2015, The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea Trial, Food Chem. Toxicol., 83, 26, 10.1016/j.fct.2015.05.019 · DOI
  101. Dostal, 2017, Green tea extract and catechol-O-methyltransferase genotype modify the post-prandial serum insulin response in a randomised trial of overweight and obese post-menopausal women, J. Hum. Nutr. Diet., 30, 166, 10.1111/jhn.12408 · DOI
  102. Dostal, 2016, Green tea extract and Catechol-O-Methyltransferase genotype modify fasting serum insulin and plasma adiponectin concentrations in a randomized controlled trial of overweight and obese postmenopausal women, J. Nutr., 146, 38, 10.3945/jn.115.222414 · DOI
  103. Lovera, 2015, Polyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatotoxic: phase I single group and phase II randomized placebo-controlled studies, J. Neurol. Sci., 358, 46, 10.1016/j.jns.2015.08.006 · DOI
  104. Chen, 2016, Therapeutic effect of high-dose green tea extract on weight reduction: a randomized, double-blind, placebo-controlled clinical trial, Clin. Nutr., 35, 592, 10.1016/j.clnu.2015.05.003 · DOI
  105. Liu, 2014, Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial, PLoS One, 9, e91163, 10.1371/journal.pone.0091163 · DOI
  106. Liu, 2013, Effect of green tea on glucose control and insulin sensitivity: a meta-analysis of 17 randomized controlled trials, Am. J. Clin. Nutr., 98, 340, 10.3945/ajcn.112.052746 · DOI
  107. Meshitsuka, 2017, Phase 2 trial of daily, oral epigallocatechin gallate in patients with light-chain amyloidosis, Int. J. Hematol., 105, 295, 10.1007/s12185-016-2112-1 · DOI
  108. Arzenton, 2012, Acute hepatitis caused by green tea infusion: a case report, Adv. Pharmacoepidemiol. Drug Saf., 170
  109. Bergman, 2009, Hepatitis Caused by Lotus‐f3?, Basic Clin. Pharmacol. Toxicol., 104, 414, 10.1111/j.1742-7843.2009.00385.x · DOI
  110. Bjornsson, 2007, Serious adverse liver reactions associated with herbal weight-loss supplements, J. Hepatol., 47, 295, 10.1016/j.jhep.2007.05.010 · DOI
  111. Chen, 2010, Acute liver injury induced by weight-loss herbal supplements, World J. Hepatol., 2, 410, 10.4254/wjh.v2.i11.410 · DOI
  112. Cruz, 2014, Mo1814 fulminant liver failure secondary to “Saba appetite control and energy” weight loss supplement, Gastroenterology, 146, 10.1016/S0016-5085(14)63644-1 · DOI
  113. Dara, 2008, Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements, World J. Gastroenterol.: WJG, 14, 6999, 10.3748/wjg.14.6999 · DOI
  114. Federico, 2007, A case of hepatotoxicity caused by green tea, Free Radic. Biol. Med., 43, 474, 10.1016/j.freeradbiomed.2007.05.010 · DOI
  115. Fernandez, 2014, Three cases of liver toxicity with a dietary supplement intended to stop hair loss, Rev. Esp. Enferm. Dig., 106, 552
  116. Fong, 2010, Hepatotoxicity due to hydroxycut®: a case series, Am. J. Gastroenterol., 105, 10.1038/ajg.2010.5 · DOI
  117. Gallo, 2013, Is green tea a potential trigger for autoimmune hepatitis?, Phytomedicine, 20, 1186, 10.1016/j.phymed.2013.07.004 · DOI
  118. Gloro, 2005, Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea, Eur. J. Gastroenterol. Hepatol., 17, 1135, 10.1097/00042737-200510000-00021 · DOI
  119. Haimowitz, 2015, Liver failure after Hydroxycut™ use in a patient with undiagnosed hereditary coproporphyria, J. Gen. Intern. Med., 30, 856, 10.1007/s11606-014-3153-x · DOI
  120. Jiménez-Encarnación, 2012, Euforia-induced acute hepatitis in a patient with scleroderma, BMJ Case Rep., 10.1136/bcr-2012-006907 · DOI
  121. Jones, 2007, Acute liver injury associated with the herbal supplement hydroxycut in a soldier deployed to Iraq, Am. J. Gastroenterol., 102, 2357, 10.1111/j.1572-0241.2007.01353_10.x · DOI
  122. Kanda, 2003, Severe hepatotoxicity associated with chinese diet product ‘Onshidou-Genbi-Kounou’, J. Gastroenterol. Hepatol., 18, 354, 10.1046/j.1440-1746.2003.02952.x · DOI
  123. Kaswala, 2014, Hydroxycut-induced liver toxicity, Ann. Med. Health Sci. Res., 4, 143, 10.4103/2141-9248.126627 · DOI
  124. McDonnell, 2009, Fulminant hepatic failure after use of the herbal weight-loss supplement exilis, Ann. Intern. Med., 151, 673, 10.7326/0003-4819-151-9-200911030-00021 · DOI
  125. Molinari, 2006, Acute liver failure induced by green tea extracts: case report and review of the literature, Liver Transpl., 12, 1892, 10.1002/lt.21021 · DOI
  126. Pillukat, 2014, Concentrated green tea extract induces severe acute hepatitis in a 63-year-old woman--a case report with pharmaceutical analysis, J. Ethnopharmacol., 155, 165, 10.1016/j.jep.2014.05.015 · DOI
  127. Porcel, 2005, Hepatotoxicity associated with green tea extracts, Ann. Intern. Med.
  128. Radha Krishna, 2011, Acute liver failure caused by ‘fat burners’ and dietary supplements: a case report and literature review, Can. J. Gastroenterol. Hepatol., 25, 157
  129. Sharma, 2010, Hydroxycut®(herbal weight loss supplement) induced hepatotoxicity: a case report and review of literature, Hawaii Med. J., 69, 188
  130. Stevens, 2005, Two patients with acute liver injury associated with use of the herbal weight-loss supplement hydroxycut [7], Ann. Intern. Med., 142, 477, 10.7326/0003-4819-142-6-200503150-00026 · DOI
  131. Stickel, 2015, Liver injury from herbal and dietary supplements, Dtsch. Med. Wochenschr., 140, 908
  132. Vanstraelen, 2008, Jaundice as a misadventure of a green tea (camellia sinensis) lover: a case report, Acta Gastroenterol. Belg., 71, 409
  133. Verhelst, 2009, Acute hepatitis after treatment for hair loss with oral green tea extracts (Camellia Sinensis), Acta Gastroenterol. Belg., 72, 262
  134. Weinstein, 2012, SlimQuick™-associated hepatotoxicity in a woman with alpha-1 antitrypsin heterozygosity, World J. Hepatol., 4, 154, 10.4254/wjh.v4.i4.154 · DOI
  135. Whitsett, 2014, SlimQuick™-associated hepatotoxicity resulting in fulminant liver failure and orthotopic liver transplantation, ACG Case Rep. J., 1, 220, 10.14309/crj.2014.59 · DOI
  136. de Paula, 2008, Hepatitis tóxica por Camellia sinensis, Gastroenterol. Hepatol., 31, 402, 10.1157/13123613 · DOI
  137. García-Cortés, 2008, Liver injury induced by" natural remedies": an analysis of cases submitted to the Spanish Liver Toxicity Registry, Rev. Esp. Enferm. Dig., 100, 688
  138. García-Morán, 2004, Hepatitis aguda asociada a ingestión de camellia thea y orthosiphon stamineus, Gastroenterol. Hepatol., 27, 559, 10.1016/S0210-5705(03)70527-5 · DOI
  139. Gavilan, 1999, Phytotherapy and hepatitis, Rev. Clin. Esp., 199, 693
  140. Lorenzo-Almorós, 2015, Hepatitis aguda por extracto de té verde, Gastroenterología y Hepatología, 38, 44, 10.1016/j.gastrohep.2014.07.004 · DOI
  141. Martínez-Sierra, 2006, Hepatitis aguda tras ingestión de té verde, Medicina Clínica, 127, 119, 10.1157/13090268 · DOI
  142. Sadornil, 2004, Hepatotoxicidad por Camelia sinensis, Med. Clin., 122, 677, 10.1016/S0025-7753(04)74349-3 · DOI
  143. Thiolet, 2002, Cytolyse aiguë après prise d’un thé chinois, Gastroentérologie clinique et biologique, 26, 939
  144. Rohde, 2011, Toksisk hepatitis udløst af grøn te, Ugeskr Læger, 173, 3
  145. Mathieu, 2005, Hépatotoxicité probable de l’X-elles® utilisé en phytothérapie, Gastroentã©rologie Clin. Biol., 29, 1188, 10.1016/S0399-8320(05)82193-1 · DOI
  146. Pedrós, 2003, Hepatotoxicidad por extracto etanólico seco de Camellia sinensis, Med Clin (Barc), 121, 598, 10.1016/S0025-7753(03)74026-3 · DOI
  147. Peyrin-Biroulet, 2004, Hépatotoxicité probable du gallate d’épigallocatéchol utilisé en phytothérapie, Gastroentérologie clinique et biologique, 28, 404, 10.1016/S0399-8320(04)94944-5 · DOI
  148. Benichou, 1993, Causality assessment of adverse reactions to drugs—II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge, J. Clin. Epidemiol., 46, 1331, 10.1016/0895-4356(93)90102-7 · DOI · Paper page
  149. Knapik, 2018, Dietary supplement use in a large, representative sample of the US armed forces, J. Acad. Nutr. Diet., 118, 1370, 10.1016/j.jand.2018.03.024 · DOI
  150. Bailey, 2013, Why US adults use dietary supplements, JAMA Intern. Med., 173, 355, 10.1001/jamainternmed.2013.2299 · DOI · Paper page
  151. Crescioli, 2018, Acute liver injury following Garcinia cambogia weight-loss supplementation: case series and literature review, Intern. Emerg. Med., 13, 857, 10.1007/s11739-018-1880-4 · DOI
  152. Brown, 2017, Liver toxicity related to herbs and dietary supplements: online table of case reports. Part 2 of 5 series, Food Chem. Toxicol., 107, 472, 10.1016/j.fct.2016.07.001 · DOI · Paper page
  153. Cohen, 2016, Emergency department visits and hospitalisations for adverse events related to dietary supplements are common, Evid. Med., 21, 79
  154. MacKay, 2016, Emergency department visits related to dietary supplements, N. Engl. J. Med., 374, 694, 10.1056/NEJMc1514454 · DOI
  155. Pascale, 2016, Dietary supplements: knowledge and adverse event reporting among American Medical Society for Sports Medicine physicians, Clin. J. Sport. Med., 26, 139, 10.1097/JSM.0000000000000213 · DOI
  156. Cirulli, 2019, A missense variant in PTPN22 is a risk factor for drug-induced liver injury, Gastroenterology, 156, 1707, 10.1053/j.gastro.2019.01.034 · DOI · Paper page
  157. Nicoletti, 2017, Association of liver injury from specific drugs, or groups of drugs, with polymorphisms in HLA and other genes in a genome-wide association study, Gastroenterology, 152, 1078, 10.1053/j.gastro.2016.12.016 · DOI · Paper page
  158. Urban, 2017, Minocycline hepatotoxicity: clinical characterization and identification of HLA-B *35:02 as a risk factor, J. Hepatol., 67, 137, 10.1016/j.jhep.2017.03.010 · DOI · Paper page
  159. Church, 2015, Sensitivity to hepatotoxicity due to epigallocatechin gallate is affected by genetic background in diversity outbred mice, Food Chem. Toxicol., 76, 19, 10.1016/j.fct.2014.11.008 · DOI
  160. Liu, 2014, Epigallocatechin-3-gallate (EGCG) attenuates concanavalin A-induced hepatic injury in mice, Acta Histochem., 116, 654, 10.1016/j.acthis.2013.12.002 · DOI
  161. Kaneko, 2000, Augmentation of Vα14 NKT cell–mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A–induced hepatitis, J. Exp. Med., 191, 105, 10.1084/jem.191.1.105 · DOI
  162. Miyazawa, 1998, Involvement of intrasinusoidal hemostasis in the development of concanavalin A-induced hepatic injury in mice, Hepatology, 27, 497, 10.1002/hep.510270225 · DOI
  163. Fabregat, 2016, TGF-beta signalling and liver disease, FEBS J., 283, 2219, 10.1111/febs.13665 · DOI · Paper page
  164. Webster, 2018, Quality of life among postmenopausal women enrolled in the Minnesota Green Tea Trial, Maturitas, 108, 1, 10.1016/j.maturitas.2017.10.013 · DOI
  165. Fabbrini, 2010, Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications, Hepatology, 51, 679, 10.1002/hep.23280 · DOI · Paper page
  166. Angulo, 2007, Obesity and nonalcoholic fatty liver disease, Nutr. Rev., 65, S57, 10.1301/nr.2007.jun.S57-S63 · DOI
  167. Mazzanti, 2015, Hepatotoxicity of green tea: an update, Arch. Toxicol., 89, 1175, 10.1007/s00204-015-1521-x · DOI · Paper page
  168. Lambert, 2010, Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice, Food Chem. Toxicol., 48, 409, 10.1016/j.fct.2009.10.030 · DOI

Cited by

Sorted by citations

Metadata

Authors
Oketch-Rabah, H. A., Roe, A. L., Rider, C. V., Bonkovsky, H. L., Giancaspro, G. I., Navarro, V., Paine, M. F., Betz, J. M., Marles, R. J., Casper, S., Gurley, B., Jordan, S. A., He, K., Kapoor, M. P., Rao, T. P., Sherker, A. H., Fontana, R. J., Rossi, S., Vuppalanchi, R., Seeff, L. B., Stolz, A., Ahmad, J., Koh, C., Serrano, J., Low Dog, T., & Ko, R.
Venue
Toxicology Reports
Publisher
Elsevier BV
Published
2020
Volume
7
Pages
386-402
ISSN
2214-7500
DOI
10.1016/j.toxrep.2020.02.008
PMC
PMC7044683
Cited by
168
References
6
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review